» Articles » PMID: 6853672

Relationship Between Thyrotropin Stimulation and Radioiodine Uptake in Lung Metastases of Differentiated Thyroid Carcinoma

Overview
Specialty Endocrinology
Date 1983 Jul 1
PMID 6853672
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

To examine whether the injection of bovine TSH (bTSH) produces maximal radioactive iodine uptake (RAIU) in lung metastases in patients with differentiated thyroid cancer, 10 patients were studied 12 times. In 10 of these studies, an initial RAIU measurement was performed immediately after 3 injections of 10 IU bTSH given immediately after T3 withdrawal. Another RAIU measurement was performed 7-19 days after T3 withdrawal. Uptake increased in all patients even when it was clearly detectable immediately after bTSH stimulation. Thus, 3 days of bTSH stimulation in these patients did not lead to maximal 131I uptake, and it could only be reached after prolonged endogenous TSH stimulation. bTSH was not injected in the 2 other patients, in whom 6 RAIU measurements were carried out. Radioiodine uptake increased with time in both patients. It appears that both the level of endogenous TSH and the length of stimulation play a determining role in RAIU. This might explain why 3 days of bTSH stimulation are insufficient to elicit maximal 131I uptake.

Citing Articles

Advances in Functional Imaging of Differentiated Thyroid Cancer.

Klain M, Zampella E, Nappi C, Nicolai E, Ambrosio R, Califaretti E Cancers (Basel). 2021; 13(19).

PMID: 34638232 PMC: 8507556. DOI: 10.3390/cancers13194748.


Examining recombinant human TSH primed ¹³¹I therapy protocol in patients with metastatic differentiated thyroid carcinoma: comparison with the traditional thyroid hormone withdrawal protocol.

Rani D, Kaisar S, Awasare S, Kamaldeep , Abhyankar A, Basu S Eur J Nucl Med Mol Imaging. 2014; 41(9):1767-80.

PMID: 24687139 DOI: 10.1007/s00259-014-2737-3.


Recombinant human thyrotropin-aided radioiodine therapy in patients with metastatic differentiated thyroid carcinoma.

Zagar I, Schwarzbartl-Pevec A, Vidergar-Kralj B, Horvat R, Besic N J Thyroid Res. 2011; 2012:670180.

PMID: 21876838 PMC: 3159002. DOI: 10.1155/2012/670180.


Sodium iodide symporter expression and radioiodine distribution in extrathyroidal tissues.

Bruno R, Giannasio P, Ronga G, Baudin E, Travagli J, Russo D J Endocrinol Invest. 2005; 27(11):1010-4.

PMID: 15754731 DOI: 10.1007/BF03345302.


Increased expression of the sodium/iodide symporter in papillary thyroid carcinomas.

Saito T, Endo T, Kawaguchi A, Ikeda M, Katoh R, Kawaoi A J Clin Invest. 1998; 101(7):1296-300.

PMID: 9525971 PMC: 508706. DOI: 10.1172/JCI1259.